Lovaza Manufacturer to Enter Consumer Healthcare Market
Pronova BioPharma (Lysaker, Norway) says it will enter the consumer healthcare market during the second half of 2012.
Answering to rising consumer interest in omega-3 products, Pronova BioPharma (Lysaker, Norway) says it will enter the consumer healthcare market during the second half of 2012. The company currently markets Omacor/Lovaza, the only omega-3 pharmaceutical drug approved for use by FDA and the EU.
Over the next 12 months, Pronova plans to build its consumer healthcare division by initiating clinical trials, adjusting manufacturing its manufacturing process for consumer products, and developing distribution channels.
GC Rieber VivoMega uses AI platform from Intelecy to boost efficiency, quality, and sustainability
August 26th 2024According to the company’s announcement, the AI platform is able to identify real-time deviations or anomalies in GC Rieber VivoMega’s processing facilities and report them via a cloud-based, comprehensive, centralized system.
